Genpact Limited
NYSE:GInformation Technology Services
-$2.73 today
- Market cap
- $7.12B
- Beta
- 0.59
- P/E (TTM)
- 8.2
- EPS (TTM)
- $3.34
- Dividend yield
- 2.59%
Volume 2.37M
Average 2.81M
G Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Genpact LimitedNYSE: G
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures growth accelerates
Q3 FY2026 capital expenditures of $16.7M (cash outflow) rose 2.2% year over year, ahead of the -14.0% change in trailing-twelve-month capital expenditures. Sequentially, it rose 160.5% from the prior quarter. Over 3 fiscal years it compounded at +12.9% a year.
Context
- Capital expenditures amounted to 1.5% of revenue in FY2025, down 0.2 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +2.2% holds above the trailing-twelve-month pace of -14.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (78.2M) USD
- Year-over-year change
- +8.3%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (78.2M) | +8.3% |
| FY2024 | 2024-12-31 | (85.24M) | -45.0% |
| FY2023 | 2023-12-31 | (58.78M) | -8.1% |
| FY2022 | 2022-12-31 | (54.39M) | +5.0% |
| FY2021 | 2021-12-31 | (57.25M) | — |
Capital Expenditures vs competitors
How G compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -14.0% is the 9th highest of 11, against a peer median of +4.8%.
- Capital expenditures amounts to 1.4% of revenue for G, versus a peer median of 2.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CN¥4.43B CNY | -3308.9% | -15.6% | 36.2% | |
| LTM Jun 2026 | $614M USD | -1.9% | -11.1% | 2.3% | |
INGMIngram Micro Holding Corporation | LTM Jun 2026 | $135.02M USD | -2.8% | -1.3% | 0.2% |
| LTM Jun 2026 | $93.09M USD | +238.7% | +9.3% | 6.9% | |
| LTM Jun 2026 | $79.3M USD | +4.9% | -29.2% | 1.7% | |
| LTM Sep 2026 | $72.21M USD | -14.0% | +12.9% | 1.4% | |
| LTM Jun 2026 | $52.67M USD | +4.7% | +5.5% | 2.4% | |
| LTM Jun 2026 | $46.73M USD | +79.5% | +15.0% | 3.9% | |
| LTM Jul 2026 | $41M USD | +5.1% | +8.6% | 0.6% | |
| LTM Jul 2026 | $37.03M USD | -56.3% | +8.7% | 0.1% | |
| LTM Jun 2026 | $26.49M USD | +69.5% | -27.5% | 1.3% | |
| Peer median (excluding G) | — | +4.8% | +2.1% | 2.0% | |
Competitors are the stored peer set for G. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 369.45M | 353.4M | 631.26M | 513.67M | 552.49M |
| Depreciation & Amortization | 167.57M | 129.52M | 103.99M | 69.78M | 94.96M |
| Deferred Income Tax | (9.26M) | (29.15M) | (157.93M) | 36.61M | 19.94M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 89.62M |
| Change in Working Capital | 87.16M | (147.08M) | (182.24M) | (100.18M) | 17.89M |
| Accounts Receivables | (11.8M) | (112.34M) | (130.79M) | (96.56M) | (44.22M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 11.74M | 14.19M | (8.22M) | 8.73M | (6.42M) |
| Other Working Capital | 87.22M | (48.92M) | (43.24M) | (12.36M) | 68.53M |
| Other Non-Cash Items | 79.37M | 136.98M | 95.74M | 95.54M | 37.95M |
| Operating Cash Flow | 694.28M | 443.67M | 490.81M | 615.42M | 812.86M |
| Capital Expenditures | (57.25M) | (54.39M) | (58.78M) | (85.24M) | (78.2M) |
| Acquisitions (Net) | (65.64M) | 17.8M | (20.17M) | 2.64M | (80.38M) |
| Purchases of Investments | 0 | 0 | 0 | (23.36M) | (350M) |
| Sales of Investments | 142K | 0 | 0 | 0 | 23.36M |
| Other Investing Activities | 0 | 0 | 0 | 0 | (10.27M) |
| Investing Cash Flow | (122.75M) | (36.59M) | (78.94M) | (105.96M) | (495.5M) |
| Debt Repayment | 49.04M | (245.86M) | (173.04M) | (58.65M) | 309.86M |
| Common Stock Issued | 35.05M | 27.75M | 39.49M | 17.22M | 17.51M |
| Common Stock Repurchased | (298.22M) | (214.08M) | (225.5M) | (252.67M) | (283.05M) |
| Dividends Paid | (80.48M) | (91.84M) | (100.01M) | (108.47M) | (117.75M) |
| Other Financing Activities | (38.28M) | (47.38M) | (23.93M) | (22.28M) | (33.38M) |
| Financing Cash Flow | (332.88M) | (571.4M) | (483M) | (424.85M) | (106.82M) |
| Effect of Forex Changes | (19.63M) | (88.37M) | 8.03M | (20.04M) | (4.96M) |
| Net Change in Cash | 219.02M | (252.69M) | (63.1M) | 64.58M | 205.59M |
| Free Cash Flow | 637.03M | 389.28M | 432.04M | 530.19M | 734.65M |
Genpact Limited
NYSE:G
Intrinsic Alpha fair value
Locked
Current Price
$41.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.